Yonhap Infomax NewsPharmaResearch Co. has denied tunneling allegations in its dealings with Pixelity, asserting that all transactions were fair and market-based, but investor skepticism persists amid ongoing governance concerns.
#YonhapInfomax #PharmaResearch #Pixelity #TunnelingAllegations #ShareholderOpposition #RevenueDependence #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=70849
#YonhapInfomax #PharmaResearch #Pixelity #TunnelingAllegations #ShareholderOpposition #RevenueDependence #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=70849
PharmaResearch Addresses Tunneling Allegations—'Transactions with Pixelity Were Fair'
PharmaResearch Co. has denied tunneling allegations in its dealings with Pixelity, asserting that all transactions were fair and market-based, but investor skepticism persists amid ongoing governance concerns.